A single transcutaneous injection with Botox® for dysthyroid lid retraction
Authors:
Open Access
- 7 May 2004
- journal article
- research article
- Published by Springer Nature in Eye
- Vol. 18 (5) , 466-469
Abstract
Purpose To evaluate the safety and efficacy of injections with botulinum toxin type A (BTTA, Botox®), given transcutaneously, in the treatment of upper lid retraction associated with thyroid eye disease (TED). Methods A total of 15 patients (21 eyes) with a stable (TED) condition, and a euthyroid state, were enrolled into the study. There were 12 females and three males from ages 23 to 52 years. A single injection, at the centrally superior tarsal border transcutaneously, aiming at the levator aponeurosis and Müller muscle, was administered into each eyelid with 5–6 U of Botox®. All patients were followed regularly for 4–6 months. Any complications, such as ptosis, diplopia, pain, or lid ecchymosis were recorded. Results All patients, except one, experienced much reduction of palpebral fissure. The mean difference of MRD1 between pre- and postinjections of Botox® at the first week was −3.1 mm, and the effect remained, at least, for 2 months. There were temporary complications of ptosis in three patients and vertical diplopia in two patients, lasting 3–4 weeks. Conclusions A single transcutaneous injection with Botox® for the treatment of thyroid lid retraction is safe and effective. Some minor complications may occur, such as ptosis and diplopia; however, it may offer an alternative and temporary method for patients with dysthyroid lid retraction, who are waiting for a staged operation of either an orbital decompression or a strabismus surgery or both.Keywords
This publication has 13 references indexed in Scilit:
- Chemodenervation in Treatment of Upper Eyelid RetractionOphthalmologica, 1997
- The Effect of Somatostatin versus Corticosteroid in the Treatment of Graves' OphthalmopathyThyroid®, 1996
- Clinical Features of Graves' Ophthalmopathy in an Incidence CohortAmerican Journal of Ophthalmology, 1996
- Results of Müllerotomy and Levator Aponeurosis Transposition for the Correction of Upper Eyelid Retraction in Graves DiseaseOphthalmology, 1995
- Octreotide and Graves' ophthalmopathy and pretibial myxoedema.BMJ, 1992
- Botulinum Toxin A-induced Protective Ptosis in Corneal DiseaseOphthalmology, 1988
- Botulinum toxin A induced protective ptosisEye, 1987
- Treatment of strabismus in adults with botulinum toxin A.British Journal of Ophthalmology, 1985
- Injection treatment of endocrine orbital myopathyDocumenta Ophthalmologica, 1984
- Treatment of dysthyroid ophthalmopathy with local guanethidine.British Journal of Ophthalmology, 1969